trending Market Intelligence /marketintelligence/en/news-insights/trending/rnopjobhlixsx34uvunm0g2 content esgSubNav
In This List

T2 Biosystems COO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


T2 Biosystems COO resigns

Joanne Spadoro resigned as COO of T2 Biosystems Inc.

Spadoro will continue to provide services as a consultant and transition to the company's scientific advisory board.

T2 Biosystems, an in vitro diagnostics company, develops diagnostic products and product candidates in the U.S.